GSK is one of the world's 10 largest pharmaceutical companies. This report shows the company's role in global pharma, its revenues, major products, expenses, etc.

The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

The company's innovative new product lineup and expansive list of patent-protected drugs create a wide economic moat, in our opinion. The magnitude of GSK's reach is evidenced by a product ...

While GSK insists it is still firmly focused on R&D, the company has latterly started to increase its portfolio of high-volume, lower-priced products, such as vaccines and consumer healthcare ...

After a product is on the market, GSK keeps looking for ways to further help patients and broaden protection. In the case of GSK’s recombinant herpes zoster vaccine, a proprietary Adjuvant ...